检索结果 - Matthias Ritgen

Refine Results
  1. 1
    Unmutated immunoglobulin variable heavy-chain gene status remains an adverse prognostic factor after autologous stem cell transplantation for chronic lymphocytic leukemia

    Unmutated immunoglobulin variable heavy-chain gene status remains an adverse prognostic factor after autologous stem cell transplantation for chronic lymphocytic leukemia 由 Matthias Ritgen, Alexandra Lange, Stephan Stilgenbauer, Hartmut Döhner, Christian Bretscher, Heidi Bosse, Ariane Stuhr, Michael Kneba, Peter Dreger

    出版 2003
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Molecular relapse in adult standard-risk ALL patients detected by prospective MRD monitoring during and after maintenance treatment: data from the GMALL 06/99 and 07/03 trials

    Molecular relapse in adult standard-risk ALL patients detected by prospective MRD monitoring during and after maintenance treatment: data from the GMALL 06/99 and 07/03 trials 由 Thorsten Raff, Nicola Gökbuget, Silke Lüschen, Regina Reutzel, Matthias Ritgen, Sebastian Irmer, Sebastian Böttcher, Heinz‐August Horst, Michael Kneba, Dieter Hoelzer, Monika Brüggemann

    出版 2006
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Minimal residual disease detection in mantle cell lymphoma: methods and significance of four-color flow cytometry compared to consensus IGH-polymerase chain reaction at initial staging and for follow-up examinations

    Minimal residual disease detection in mantle cell lymphoma: methods and significance of four-color flow cytometry compared to consensus IGH-polymerase chain reaction at initial sta... 由 Sebastian Böttcher, Matthias Ritgen, Sebastian Buske, Stefan Gesk, W. Klapper, Eva Hoster, Wolfgang Hiddemann, Michael Unterhalt, Martin Dreyling, Reiner Siebert, Michael Kneba, Christiane Pott

    出版 2008
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Standardized MRD flow and ASO IGH RQ-PCR for MRD quantification in CLL patients after rituximab-containing immunochemotherapy: a comparative analysis

    Standardized MRD flow and ASO IGH RQ-PCR for MRD quantification in CLL patients after rituximab-containing immunochemotherapy: a comparative analysis 由 Sebastian Böttcher, Stephan Stilgenbauer, Robert Busch, Monika Brüggemann, Thorsten Raff, Christiane Pott, Kirsten Fischer, Guenter Fingerle-Rowson, Hartmut Döhner, Michael Hallek, Michael Kneba, Matthias Ritgen

    出版 2009
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Graft-versus-leukemia activity may overcome therapeutic resistance of chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene status: implications of minimal residual disease measurement with quantitative PCR

    Graft-versus-leukemia activity may overcome therapeutic resistance of chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene status: implications of m... 由 Matthias Ritgen, Stephan Stilgenbauer, Nils von Neuhoff, Andreas Humpe, Monika Brüggemann, Christiane Pott, Thorsten Raff, Alexander Kröber, Donald Bunjes, Richard F. Schlenk, Norbert Schmitz, Hartmut Döhner, Michael Kneba, Peter Dreger

    出版 2004
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    Quantitative assessment of molecular remission after high-dose therapy with autologous stem cell transplantation predicts long-term remission in mantle cell lymphoma

    Quantitative assessment of molecular remission after high-dose therapy with autologous stem cell transplantation predicts long-term remission in mantle cell lymphoma 由 Christiane Pott, Carsten Schrader, Stefan Gesk, Lana Harder, Markus Tiemann, Thorsten Raff, Monika Brüggemann, Matthias Ritgen, B. Gahn, Michael Unterhalt, Martin Dreyling, Wolfgang Hiddemann, Reiner Siebert, Peter Dreger, Michael Kneba

    出版 2005
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disorders

    Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disorders 由 Marco Ladetto, Monika Brüggemann, Luigia Monitillo, Simone Ferrero, François Pépin, Daniela Drandi, Diego Barbero, Antonio Palumbo, Roberto Passera, Mario Boccadoro, Matthias Ritgen, Nicola Gökbuget, Jianbiao Zheng, Victoria Carlton, Heiko Trautmann, Malek Faham, Christiane Pott

    出版 2013
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    High efficacy of venetoclax plus obinutuzumab in patients with complex karyotype and chronic lymphocytic leukemia

    High efficacy of venetoclax plus obinutuzumab in patients with complex karyotype and chronic lymphocytic leukemia 由 Othman Al‐Sawaf, Esther Lilienweiss, Jasmin Bahlo, Sandra Robrecht, Anna-Maria Fink, Michaela Patz, Maneesh Tandon, Yanwen Jiang, William Schary, Matthias Ritgen, Eugen Tausch, Stephan Stilgenbauer, Barbara Eichhorst, Kirsten Fischer, Michael Hallek, Karl‐Anton Kreuzer

    出版 2020
    获取全文 获取全文
    Carta
    加到收藏夹
    Saved in:
  9. 9
    Minimal Residual Disease Quantification Is an Independent Predictor of Progression-Free and Overall Survival in Chronic Lymphocytic Leukemia: A Multivariate Analysis From the Randomized GCLLSG CLL8 Trial

    Minimal Residual Disease Quantification Is an Independent Predictor of Progression-Free and Overall Survival in Chronic Lymphocytic Leukemia: A Multivariate Analysis From the Rando... 由 Sebastian Böttcher, Matthias Ritgen, Kirsten Fischer, Stephan Stilgenbauer, Raymonde M. Busch, Günter Fingerle‐Rowson, Anna Maria Fink, Andreas Bühler, Thorsten Zenz, Michael Wenger, Myriam Mendila, Clemens‐Martin Wendtner, Barbara Eichhorst, Hartmut Döhner, Michael Hallek, Michael Kneba

    出版 2012
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    Effect of first-line treatment on second primary malignancies and Richter’s transformation in patients with CLL

    Effect of first-line treatment on second primary malignancies and Richter’s transformation in patients with CLL 由 Christian Maurer, Petra Langerbeins, Jasmin Bahlo, Paula Cramer, Anna‐Maria Fink, Natali Pflug, Anja Engelke, Julia von Tresckow, Gábor Kovács, Stephan Stilgenbauer, C-M Wendtner, Lothar Müller, Matthias Ritgen, T. Seiler, Kirsten Fischer, Michael Hallek, Barbara Eichhorst

    出版 2016
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  11. 11
    A model for predicting effect of treatment on progression-free survival using MRD as a surrogate end point in CLL

    A model for predicting effect of treatment on progression-free survival using MRD as a surrogate end point in CLL 由 Natalie Dimier, Paul Delmar, Carol Ward, Rodica Morariu-Zamfir, Günter Fingerle‐Rowson, Jasmin Bahlo, Kirsten Fischer, Barbara Eichhorst, Valentin Goede, Jacques J. M. van Dongen, Matthias Ritgen, Sebastian Böttcher, Anton W. Langerak, Michael Kneba, Michael Hallek

    出版 2017
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    Genes encoding members of the <scp>JAK</scp>‐<scp>STAT</scp> pathway or epigenetic regulators are recurrently mutated in T‐cell prolymphocytic leukaemia

    Genes encoding members of the <scp>JAK</scp>‐<scp>STAT</scp> pathway or epigenetic regulators are recurrently mutated in T‐cell prolymphocytic leukaemia 由 Cristina López, Anke K. Bergmann, Ulrike Paul, Eva Maria Murga Penas, Inga Nagel, Matthew J. Betts, Patricia Johansson, Matthias Ritgen, Tycho Baumann, Marta Aymerich, Sandrine Jayne, Robert B. Russell, Elı́as Campo, Martin J.S. Dyer, Jan Dürig, Reiner Siebert

    出版 2016
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  13. 13
    &lt;i&gt;DUX4r&lt;/i&gt;, &lt;i&gt;ZNF384r&lt;/i&gt; and &lt;i&gt;PAX5&lt;/i&gt;-P80R mutated B-cell precursor acute lymphoblastic leukemia frequently undergo monocytic switch

    &lt;i&gt;DUX4r&lt;/i&gt;, &lt;i&gt;ZNF384r&lt;/i&gt; and &lt;i&gt;PAX5&lt;/i&gt;-P80R mutated B-cell precursor acute lymphoblastic leukemia frequently undergo monocytic switch 由 Michaela Nováková, Markéta Žaliová, Karel Fišer, Barbora Vakrmanová, Lucie Slámová, Alena Musilová, Monika Brüggemann, Matthias Ritgen, Eva Froňková, Tomáš Kalina, Jan Starý, Lucie Winkowska, Peter Švec, Alexandra Kolenová, Jan Stuchlý, Jan Zuna, Jan Trka, Ondřej Hrušák, Ester Mejstříková

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  14. 14
    TP53, SF3B1, and NOTCH1 mutations and outcome of allotransplantation for chronic lymphocytic leukemia: six-year follow-up of the GCLLSG CLL3X trial

    TP53, SF3B1, and NOTCH1 mutations and outcome of allotransplantation for chronic lymphocytic leukemia: six-year follow-up of the GCLLSG CLL3X trial 由 Peter Dreger, Andrea Schnaiter, Thorsten Zenz, Sebastian Böttcher, Marianna Rossi, Peter Paschka, Andreas Bühler, Sascha Dietrich, Raymonde Busch, Matthias Ritgen, Donald Bunjes, Matthias Zeis, Michael Stadler, Lutz Uharek, Christof Scheid, Ute Hegenbart, Michael Hallek, Michael Kneba, Norbert Schmitz, Hartmut Döhner, Stephan Stilgenbauer

    出版 2013
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  15. 15
    Novel Flow Cytometric Antibody Panel and Dedicated Analysis Algorithm for Automated Fully Standardized Minimal Residual Disease Detection in Chronic Lymphocytic Leukemia

    Novel Flow Cytometric Antibody Panel and Dedicated Analysis Algorithm for Automated Fully Standardized Minimal Residual Disease Detection in Chronic Lymphocytic Leukemia 由 R. Engelmann, Juan Flores‐Montero, Joyce Schilperoord‐Vermeulen, Matthias Ritgen, Paul J. Hengeveld, Saskia Kohlscheen, Georgiana Grigore, Rafael Fluxa Rodriguez, Quentin Lécrevisse, Jan Philippé, Neus Villamor, Paula Fernández, Leire Burgos, Jacques J. M. van Dongen, Alberto Órfão, A. W. Langerak, Sebastian Böttcher

    出版 2025
    获取全文
    Carta
    加到收藏夹
    Saved in:
  16. 16
    First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia

    First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia 由 Barbara Eichhorst, Raymonde Busch, Stephan Stilgenbauer, Martina Stauch, Manuela A. Bergmann, Matthias Ritgen, N Kranzhöfer, Robert Rohrberg, Ulrike Söling, Oswald Burkhard, Anne Westermann, Valentin Goede, Carmen D. Schweighofer, Kirsten Fischer, Anna‐Maria Fink, Clemens‐Martin Wendtner, Günter Brittinger, Hartmut Döhner, Bertold Emmerich, Michael Hallek

    出版 2009
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  17. 17
    Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study Group CLL3X trial

    Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study Group CL... 由 Peter Dreger, Hartmut Döhner, Matthias Ritgen, Sebastian Böttcher, Raymonde Busch, Sascha Dietrich, Donald Bunjes, Sandra Cohen, Jörg Schubert, Ute Hegenbart, Dietrich W. Beelen, Matthias Zeis, Michael Stadler, Justin Hasenkamp, Lutz Uharek, Christof Scheid, Andreas Humpe, Thorsten Zenz, Dirk Winkler, Michael Hallek, Michael Kneba, Norbert Schmitz, Stephan Stilgenbauer

    出版 2010
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  18. 18
    Minimal Residual Disease Dynamics after Venetoclax-Obinutuzumab Treatment: Extended Off-Treatment Follow-up From the Randomized CLL14 Study

    Minimal Residual Disease Dynamics after Venetoclax-Obinutuzumab Treatment: Extended Off-Treatment Follow-up From the Randomized CLL14 Study 由 Othman Al‐Sawaf, Can Zhang, Tong Lu, Michael Z. Liao, Anesh Panchal, Sandra Robrecht, Travers Ching, Maneesh Tandon, Anna‐Maria Fink, Eugen Tausch, Christof Schneider, Matthias Ritgen, Sebastian Böttcher, Karl‐Anton Kreuzer, Brenda Chyla, Dale Miles, Clemens‐Martin Wendtner, Barbara Eichhorst, Stephan Stilgenbauer, Yanwen Jiang, Michael Hallek, Kirsten Fischer

    出版 2021
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  19. 19
    Expert-independent classification of mature B-cell neoplasms using standardized flow cytometry: a multicentric study

    Expert-independent classification of mature B-cell neoplasms using standardized flow cytometry: a multicentric study 由 Sebastian Böttcher, R. Engelmann, Georgiana Grigore, Paula Fernández, Joana Caetano, Juan Flores‐Montero, Vincent H. J. van der Velden, Michaela Nováková, Jan Philippé, Matthias Ritgen, Leire Burgos, Quentin Lécrevisse, Sandra Lange, Tomáš Kalina, Javier Verde Velasco, Rafael Fluxa Rodriguez, Jacques J. M. van Dongen, Carlos E. Pedreira, Alberto Órfão

    出版 2021
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  20. 20
    Bendamustine in Combination With Rituximab for Previously Untreated Patients With Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study Group

    Bendamustine in Combination With Rituximab for Previously Untreated Patients With Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leuke... 由 Kirsten Fischer, Paula Cramer, Raymonde Busch, Sebastian Böttcher, Jasmin Bahlo, Jöerg Schubert, Karl Heinz Pflüger, Silke Schott, Valentin Goede, Susanne Isfort, Julia von Tresckow, Anna‐Maria Fink, Andreas Bühler, Dirk Winkler, Karl‐Anton Kreuzer, Peter Staib, Matthias Ritgen, Michael Kneba, Hartmut Döhner, Barbara Eichhorst, Michael Hallek, Stephan Stilgenbauer, Clemens‐Martin Wendtner

    出版 2012
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: